Author(s):
Sadik Almeklafi, Bilal Al-Shahoud, Mohammad Moner, Maya Tarboosh, Reem Ersaly, Baraah Alkazak, Fakhreya Al Hadar
Email(s):
ahmedsarhan1966@gmail.com
DOI:
10.52711/0974-360X.2025.00669
Address:
Sadik Almeklafi*, Bilal Al-Shahoud, Mohammad Moner, Maya Tarboosh, Reem Ersaly, Baraah Alkazak, Fakhreya Al Hadar
Department of Pharmaceutical Chemistry and Quality Control, Faculty of Pharmacy, University of Kalamoon, Deir Atiyah, Syrian Republic.
*Corresponding Author
Published In:
Volume - 18,
Issue - 10,
Year - 2025
ABSTRACT:
Azithyromcin an antmicrobial medication, and belongs to a new class of azalide antimicrobials that belongs to the macrolide group of S50 protein inhibitors. Continuous monitoring of pharmaceutical products is vital because it is important for human health, Azithromycin recently more used effectively for treatment of lower and upper respiratory tract gram-negative and may gram-positive organisms in cases of resistance to anther antibiotics used for these diseases. A set of physicochemical and microbiological tests and quality control tests using the modified constitutional chromatography method to assessment Azithromycin tablets quality of various national Syrian brands and compared to reference international band (Azicip ®), the results of these tests showed that acceptable limit so can be used safely with suitable cost. The results of tests that used for evaluation; uniformity of weight, hardness, friability, and microbial assay. Their results ranged between ;651 mg to 902.5 mg, 14.91±0.42 to 19.58±0.43 (Kg/cm2), 0.02 to 0.5%, 94.18 to 98.32%, (mean ± S.D) respectively. All tablets disintegrated within 3.8 to 8 minutes with distilled water. The dissolution (%) in 0.1 N HCL and phosphate buffer solution pH = 6.0 at 37.0 ± 0.5 °C after 45 minutes was between 87% to 92% by using HPLC device. The results of assay were (99.4 %, 97.8 %, 98.6 %, 97.4 %) of A, B, C of local companies and D of reference company respectively, these results were acceptable according to USP Pharmacopeia limit. The validation of the analytical method was verified in which, the value of limit of detection (LOD) was 0.0933 µg/ml, the value of limit of quantification (LOQ) was 0.311 µg/ml, correlation coefficient R value was 0.9998 that indicated the linearity of applied method within the range of concentration (27.25- 132.14 %).
Cite this article:
Sadik Almeklafi, Bilal Al-Shahoud, Mohammad Moner, Maya Tarboosh, Reem Ersaly, Baraah Alkazak, Fakhreya Al Hadar. Quality Control Evaluation and In - vitro Equivalence of Various Brands of Marketed Azithromycin Tablets. Research Journal of Pharmacy and Technology. 2025;18(10):4653-9. doi: 10.52711/0974-360X.2025.00669
Cite(Electronic):
Sadik Almeklafi, Bilal Al-Shahoud, Mohammad Moner, Maya Tarboosh, Reem Ersaly, Baraah Alkazak, Fakhreya Al Hadar. Quality Control Evaluation and In - vitro Equivalence of Various Brands of Marketed Azithromycin Tablets. Research Journal of Pharmacy and Technology. 2025;18(10):4653-9. doi: 10.52711/0974-360X.2025.00669 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-10-8
REFERENCES:
1. Jaber SH. Salih ZT. Salmo HM. Formulation of azithromycin suspension as an oral dosage form. Iraqi J Pharm Sci. 2012; 21: 61-69. DOI: https://doi.org/10.31351/vol21iss1pp61-69
2. Parnham MJ.Erakovic Haber V. Giamarellos-Bourboulis EJ. Perletti G. Verleden GM. Vos R. Azithromycin mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014; Aug; 143(2): 225-45. doi: 10.1016/j.pharmthera.2014.03.003.
3. Bakheit AH. Al-Hadiya BM. Abd-Elgalil AA. Azithromycin. Profiles Drug Subst Excip Relat Methodol. 2014; 39: 1-40. doi: 10.1016/B978-0-12-800173-8.00001-5.
4. Daley CL. Mycobacterium avium Complex Disease. Microbiol Spectr. 2017; Apr; 5(2). doi: 10.1128/microbiolspec.TNMI7-0045-2017.
5. Jensen JS. Cusini M. Gomberg M.Moi H. European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016; Oct; 30(10): 1650-1656. DOI: 10.1111/jdv.13849
6. C L Pacifico. C Chiesa. Azithromycin in children: A critical review of the evidence. Current Therapeutic Research. 2002; 63: 54-76. https://doi.org/10.1016/S0011-393X(02)80007-8
7. Krause PJ. Lepore T.Sikand VK.Gadbaw J. Burke G. Telford SR. Brassard P. Pearl D. Azlanzadeh J. Christianson D. McGrath D,s Spielman A. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000; Nov 16; 343(20): 1454-8. DOI: 10.1056/NEJM200011163432004
8. Dunne MW. Singh N. Shukla M. Valecha N.Bhattacharyya PC. Dev V. Patel K. Mohapatra MK.Lakhani J. Benner R. Lele C. Patki K A. multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis. 2005; May 15; 191(10): 1582-8. doi: 10.1086/429343. Epub 2005 Apr 11.
9. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls Publishing; 2021.
10. Patel J, Berezowski I, Abdelmonem A, Taylor D, Pourmand A. Azithromycin for mild- to moderate COVID-19. Lancet Respir Med. 2021; 9(10): 99: http://dx.doi.org/10.1016/S2213-2600(21)00379-922. PMID: 34509194.
11. Vos R. Vanaudenaerde BM. Verleden SE. De Vleeschauwer SI. Willems-Widyastuti A. Van Raemdonck DE. Schoonis A. Nawrot TS. Dupont LJ. Verleden GM. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J. 2011; Jan; 37(1): 164-72. DOI: 10.1183/09031936.00068310
12. World Health Organization. WHO model list of essential medicines– 22nd list, 2021
13. Ms. Padse Pragati U. Mr. Mohan Rahul S.Dr. Kawade Rajendra M3. Quality Control Assessment On Comparative Study Of Different Marketed Brands Of Azithromycin Tablet. IJCRT. 2024; June, Volume 12, Issue 6: 230-238
14. Yesuneh Tefera MekashaID. Belachew Umeta Chali. Anbessa Bekele Feissa.Gemmechu Hasen GodenaID. Hassen Kebede Hassen. Sultan Suleman Wega. Quality evaluation of the Azithromycin tablets commonly marketed in Adama, and Modjo towns, Oromia Regional State, Ethiopia. journal.pone. 2023; March 2, l0282156. DOI: 10.1371/journal.pone.0282156
15. WHO. Revision of monograph on tablets, 2011. [Accessed October 25, 2018].
16. Md. Sahab Uddin. Abdullah Al Mamun.Tanjuma Tasnu and Md. Asaduzzaman. In-process and finished products quality control tests for pharmaceutical tablets according to Pharmacopoeias. Journal of Chemical and Pharmaceutical Research. 2015; 7(9): 180-185
17. British Pharmacopeia Commission-2013 British Pharmacopeia, 13th Edition.
18. USP 2023 (United State Pharmacopeia 46 - NF 41) (webofpharma.com), pp (1216) Tablet Friability
19. Oral Solid Dosage Form Disintegration Testing the forgotten test Jozef AL-Gousous, Peter Langguth
20. Thai pharmacopeia
21. USP 2023 (United State Pharmacopeia 46 - NF 41) (webofpharma.com), Azithromycin Tablets
22. Development of a Simple RP-HPLC-UV Method for Determination of Azithromycin in Bulk and Pharmaceutical Dosage forms as an Alternative to the USP Method.
23. Validation of HPLCTechniques for Pharmaceutical Analysis. Pharmaceutical Chemistry Journal. April 2004; 38(4): 212-228
24. hptts://squareup.com (SQUAR company)
25. Long C M. Biopharmaceutical considerations and in vitro-in vivo correlations (IVIVCs) for orally administered amorphous formulations. Doctoral Thesis. University of Bath. 2014; 1-251.